From the Department of Emergency Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
School of Pharmacy, Ohio State University, Columbus.
Pediatr Emerg Care. 2021 Sep 1;37(9):e500-e506. doi: 10.1097/PEC.0000000000002513.
To evaluate procedural sedation (PS) in infants/children, performed by emergency physicians in a general (nonpediatric) emergency department (ED).
Procedural sedation prospectively recorded on a standardized form over 15 years. Demographics, sedatives, and analgesia associations with adverse events were explored with logistic regressions.
Of 3274 consecutive PS, 1177 were pediatric: 2 months to 21 years, mean age (±SD) 8.7 ± 5.2 years, 63% boys, 717 White, 435 Black, 25 other. Eight hundred and seventy were American Society of Anesthesiology (ASA) 1, 256 ASA 2, 39 ASA 3, 11 ASA 4, 1 ASA 5. Procedural sedation indications are as follows: fracture reduction (n = 649), dislocation reduction (n = 114), suturing/wound care (n = 244), lumbar puncture (n = 49), incision and drainage (n = 37), foreign body removal (n = 28), other (n = 56). Sedatives were ketamine (n = 762), propofol ( = 354), benzodiazepines (n = 157), etomidate (n = 39), barbiturates (n = 39). There were 47.4% that received an intravenous opioid. Success rate was 100%. Side effects included nausea/vomiting, itching/rash, emergence reaction, myoclonus, paradoxical reaction, cough, hiccups. Complications were oxygen desaturation less than 90%, bradypnea respiratory rate less than 8, apnea, tachypnea, hypotension, hypertension, bradycardia, tachycardia. Normal range of vital signs was age-dependent. Seventy-four PS (6.3%) resulted in a side effect and 8 PS (3.2%) a complication. No one died, required hospital admission, intubation, or any invasive procedure.
Adverse events in infants/children undergoing PS in a general ED are low and comparable to a pediatric ED at a children's hospital. Pediatric PS can be done safely and effectively in a general ED by nonpediatric EM physicians for a wide array of procedures.
评估由急诊医师在普通(非儿科)急诊室进行的婴儿/儿童程序性镇静(PS)。
15 年来,前瞻性地在标准化表格上记录 PS。使用逻辑回归探讨了与不良事件相关的人口统计学、镇静剂和镇痛剂。
在连续 3274 例 PS 中,有 1177 例为儿科:2 个月至 21 岁,平均年龄(±SD)8.7±5.2 岁,63%为男性,717 例为白人,435 例为黑人,25 例为其他种族。870 例为美国麻醉医师协会(ASA)1 级,256 例为 ASA 2 级,39 例为 ASA 3 级,11 例为 ASA 4 级,1 例为 ASA 5 级。PS 的适应证如下:骨折复位(n=649)、脱位复位(n=114)、缝合/伤口护理(n=244)、腰椎穿刺(n=49)、切开引流(n=37)、异物取出(n=28)、其他(n=56)。镇静剂为氯胺酮(n=762)、异丙酚(n=354)、苯二氮䓬类(n=157)、依托咪酯(n=39)、巴比妥类(n=39)。有 47.4%的患儿接受了静脉阿片类药物。成功率为 100%。不良反应包括恶心/呕吐、瘙痒/皮疹、苏醒反应、肌阵挛、矛盾反应、咳嗽、呃逆。并发症包括氧饱和度低于 90%、呼吸频率低于 8 次/分、呼吸暂停、呼吸急促、低血压、高血压、心动过缓、心动过速。生命体征的正常范围与年龄有关。74 例 PS(6.3%)出现不良反应,8 例 PS(3.2%)出现并发症。无死亡、住院、插管或任何有创操作。
在普通 ED 中接受 PS 的婴儿/儿童的不良事件发生率较低,与儿童医院的儿科 ED 相当。非儿科急诊医师可为广泛的操作在普通 ED 中安全有效地进行儿科 PS。